Article
Recurrent parasitemias with artemisinin partial resistance mutations during the 2024 Ethiopia malaria resurgence: a case series.
Malaria journal - 31 Jul 2026
Geleta Dessalegn, Brhane Bokretsion G, Abera Adugna, Belachew Mahlet, Sime Heven, Gebreegziaxher Atsbeha, Getu Melak, Ali Abraham, Tesfay Neamin, Habtetsion Medhanye, Kokobe Belayneh, Kebede Mandefro, Worku Zemene, Tasew Geremew, Tadesse Gemechu, Tollera Getachew, Fola Abebe A, Bailey Jeffrey A, Juliano Jonathan J, Parr Jonathan B, Abte Melkamu, Assefa Ashenafi
Abstract excerpt
BACKGROUND: Ethiopia experienced a marked resurgence of malaria in 2024. Artemisinin-based combination therapies (ACTs) are first-line treatment for uncomplicated Plasmodium falciparum malaria and are threatened by the emergence of artemisinin partial resistance (ART-R), which is associated with mutations in the P. falciparum kelch13 (k13) gene, that could undermine treatment efficacy and accelerate transmission....
Read the complete abstract on PubMedTopics
- Ethiopia
- Artemisinins
- Drug Resistance
- Plasmodium falciparum
